We developed potent and selective aminocyclopentane-derived inhibitors of human -acetyl-β-D-glucosaminidase (OGA) implicated in Alzheimer's disease. For example compound 13 was a nanomolar OGA inhibitor with 92 000-fold selectivity over human HexB. It was non-toxic and increased protein -GlcNAcylation in the culture of murine neural cells, showing new alternatives in the treatment of tauopathies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d2cc02712g | DOI Listing |
Publication Analysis
Top Keywords
alzheimer's disease
8
diaminocyclopentane-derived -glcnacase
4
-glcnacase inhibitors
4
inhibitors combating
4
combating tau
4
tau hyperphosphorylation
4
hyperphosphorylation alzheimer's
4
disease developed
4
developed potent
4
potent selective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!